Expert consensus on the selection of topics for comprehensive clinical evaluation of drugs

Title: Expert consensus on the selection of topics for comprehensive clinical evaluation of drugs
Edition: Original
Classification: Experts consensus
Field: Comprehensive guideline
Countries and regions: China
Guidelines users: Researchers and implementation-related subjects of clinical comprehensive evaluation of drugs
Evidence classification method: This study is based on expert consensus and does not set evidence grading method
Development unit: Center for Drug Use Monitoring and Clinical Comprehensive Evaluation in Beijing
Registration time: 2024-03-22
Registration number: PREPARE-2024CN441
Purpose of the guideline: In order to standardize the selection process of topics for drug clinical comprehensive evaluation and better focus on the needs of health decision-making in China, this expert consensus was formulated.